Home > Newsletters > FDAnews Device Daily Bulletin > FDA to Industry: More Is Better When Telling Agency of Manufacturing Change
FDAnews Device Daily Bulletin
Sept. 6, 2012 | Vol. 9 No. 175
FDA to Industry: More Is Better When Telling Agency of Manufacturing Change
FDA officials sounded a familiar drumbeat during a Tuesday meeting on ways to notify the agency about changes to PMA products, asking devicemakers to submit more complete information upfront to ensure their submissions can be processed quickly. The joint FDA-AdvaMed meeting at the agency’s White Oak, Md., headquarters was held in advance of a planned pilot program that will transfer reviews of cardiovascular device submissions, such as annual reports and 30-day notices, from the Office of Compliance to the Office of Device Evaluation.
Devices & Diagnostics Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.